1 Underrated Reason to Buy Eli Lilly Stock
Eli Lilly (NYSE: LLY) is a top growth stock to own. The business is worth $560 billion, and that valuation is likely to get bigger in the years ahead. You might be tempted to buy the stock for the company's well-diversified product portfolio or perhaps for Zepbound, a weight-loss treatment that regulators recently approved, which could generate tens of billions in revenue.
Those are all solid reasons to invest in the company, but there's also one you may not have considered: its dividend. Although Eli Lilly's payout doesn't look like anything to get excited about (it currently yields less than 1%), that's deceptively low. The yield is another great reason to consider holding the stock in your portfolio.
Here's why you shouldn't discount Eli Lilly as a top dividend stock.
Source Fool.com
